Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

End-Payor Actions Consolidated In Propranolol Antitrust Row

End-Payor Actions Consolidated In Propranolol Antitrust Row

A New York federal judge Thursday Consolidated two end-payer cases in a proposed class action alleging that drugmakers conspired to jack up the price of generic blood pressure medication propranolol, and rejected a motion for separate trials for cases filed by direct purchasers.



This post first appeared on Law360, please read the originial post: here

Share the post

End-Payor Actions Consolidated In Propranolol Antitrust Row

×

Subscribe to Law360

Get updates delivered right to your inbox!

Thank you for your subscription

×